ERVW-1 and lung adenocarcinoma: Interestingly, HERV Env proteins at this location show increased antigenicity, leading to anti-tumor antibody secretion, and these effects are enhanced using immune checkpoint blockade, while the determination of the HERV expression levels in lung adenocarcinoma may be a prognostic factor of response to such therapeutic approaches [104].